Drug intelligence / Profile preview

IMT-P8

Development stage
Unknown
Lead developer
Institute of Microbial Technology
Modality
Peptides
Administration
Topical, Parenteral, Ex Vivo
01

Overview

IMT-P8 is an arginine-rich cell-penetrating peptide derived from the voltage-dependent L-type calcium channel subunit alpha-1D. It is designed to efficiently internalize into various cell types via endocytosis, enhancing the delivery of large molecules such as proteins, peptides, and nucleic acids intracellularly and across biological barriers, including the skin. IMT-P8 shows low toxicity, can permeabilize both outer and cytoplasmic membranes of bacteria, and is particularly studied as an antibiotic adjuvant. It potentiates the activity of multiple classes of antibiotics, enabling Gram-positive specific agents to become active against multidrug-resistant Gram-negative and Gram-positive bacteria by facilitating their uptake. IMT-P8 has been tested in murine infection models, demonstrating safety and efficacy, and has also been explored in topical formulations for protein, peptide, and nucleic acid delivery, as well as for cosmeceutical skin applications[1][2][3][4][5][6][7][8][9][10].

02

Targets

CM/OM (Bacterial cytoplasmic and outer membranes)

Beyond the preview

Go deeper on IMT-P8.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMT-P8.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call